Tolvaptan-Octreotide LAR Combination in ADPKD

Clinical trial NCT03541447 · COMPLETED

Trial details

NCT number: NCT03541447
Sponsor: Mario Negri Institute for Pharmacological Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease

Start date: 2018-12-12
Primary completion: 2021-12-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.